TY -
GEN
AU - Teicher, Beverly A.
TI -
Cancer Drug Resistance
PB - Humana Press Inc
SN - 9781597450355
KW - Medicine
KW - Oncology
KW - Medicine & Public Health
KW - Drug Resistance, Neoplasm
KW - Antineoplastic Agents therapeutic use
KW - Krebs Medizin
KW - Arzneimittelresistenz
KW - Pharmakotherapie
PY - 2006
N2 - Includes bibliographical references and index
N2 - Front Matter; The Cycle Between Angiogenesis, Perfusion, and Hypoxia in Tumors; Influence of Tumor pH on Therapeutic Response; Tumor Oxygenation and Treatment Response; Oncogenes and Tumor Suppressor Genes in Therapeutic Resistance; PET Imaging of Response and Resistance to Cancer Therapy; Cancer Stem Cells Implications for Development of More Effective Therapies; Therapeutic Resistance in Leukemia; Tumor Site Implantation and Animal Model Selection in Oncology; In Vivo Resistance; Characteristics of the Metastatic Phenotype; The Microenvironment and Drug Resistance
N2 - Glutathione and Glutathione S -Transferases in Drug ResistanceMetallothioneins in Drug Resistance; Molecular Determinants of Intrinsic Multidrug Resistance in Cancer Cells and Tumors; New and Revised Concepts in Multidrug Resistance; Cisplatin Resistance; Regulation of the Cellular Pharmacology and Cytotoxicity of Cisplatin by Copper Transporters; Resistance To Taxanes; CpG Island Methylation and Drug Resistance; De Novo and Acquired Resistance to Antitumor Alkylating Agents; Resistance to Antiangiogenic Agents; Resistance to Antiestrogens
N2 - Mechanisms of Glucocorticoid Actions and Resistance in Multiple MyelomaHerceptin Resistance; Role of TGF-ß in Tumor Progression and Metastasis; p53-Based Immunotherapy of Cancer; Response and Resistance to Ionizing Radiation; Amplification in DNA Copy Numbers as a Mechanism of Acquired Drug Resistance; Cancer Chemotherapy; Molecular Profiling in Breast Cancer; Tumor Immune Escape Mechanisms; Back Matter
BT - Cancer Drug Discovery and Development
BT - SpringerLink ; Bücher
CY - Totowa, NJ
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -